Purchase Of Rapid Syndromic Molecular Testing Reagents For Seattle Vamc
Solicitation · Washington
Source: SAM.gov
Our scope is to acquire specific FDA-approved infectious disease and oncology assays formulated as single-use test cartridges and reagents that are equal to and/or compatible to what is currently being used on the VA owned instrument/analyzer. Required rapid molecular assays include targets for C. difficile, SARS-CoV-2 with Influenza A & B and RSV, Strep A, MTB IVD – Mycobacterium tuberculosis wit
- Status
- Prospective
- Sector
- Manufacturing (Industrial), Residential, Commercial
- Location
- Seattle, Washington, United States of America
- Updated
- 3 Nov 2026
- Source
- SAM.gov
ConstructChat
Ask ConstructChat about Purchase Of Rapid Syndromic Molecular Testing Reagents For Seattle Vamc
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | solicitation |
Taiyo status | Prospective |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | Our scope is to acquire specific FDA-approved infectious disease and oncology assays formulated as single-use test cartridges and reagents that are equal to and/or compatible to what is currently being used on the VA owned instrument/analyzer. Required rapid molecular assays include targets for C. difficile, SARS-CoV-2 with Influenza A & B and RSV, Strep A, MTB IVD – Mycobacterium tuberculosis with Rif, MVP-Multiplex Vaginal Panel, GI Panel, MRSA Carba-R, Norovirus, BCR-ABL, FII & FV and vanA PCR. The kit storage temperature should be 2 – 28°C and not require refrigeration. Time and date of delivery to be determined by the PSHCS Microbiology Department. |
Original sector | Not Identified |
Location
Country | United States of America (USA) |
State | Washington |
City | Seattle |
Source
Source | SAM.gov |
URL |
More Details
Record type | Tender |
Sector | Manufacturing (Industrial), Residential, Commercial |
Article published date | 2026-08-20 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender